The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

Human Gene Therapy

Volumn 9, Issue 16, 1998, Pages 2363-2373

  Hemmi, S ^a   Geertsen, R ^b   Mezzacasa, A ^a   Peter, I ^a   Dummer, R ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; HLA ANTIGEN CLASS 1; INTEGRIN; INTERLEUKIN 12; VIRUS RECEPTOR;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; COXSACKIE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; NONHUMAN; VIRUS RECOMBINANT;

EID: 0032212265     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.16-2363     Document Type: Article

References (6)

1. BERGELSON, J.M., CUNNINGHAM, J.A., DROGUETT, G., KURT-JONES, E.A., KRITHIVAS, A., HONG, J.S., HORWITZ, M.S., CROWELL, R.L., and FINBERG, R.W. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
2. CORDELL, J.L., FALINI, B., ERBER, W.N., GHOSH, A.K., ABDU-LAZIZ, Z., MACDONALD, S., PULFORD, K.A., STEIN, H., and MASON, D.Y. (1984). Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32, 219-229.
3. CRYSTAL, R.G. (1997). Managed care for viruses. Nature Med. 3, 383-384.
4. DEFER, C., BELIN, M.T., CAILLET-BOUDIN, M.L., and BOULANGER, P. (1990). Human adenovirus-host cell interactions: Comparative study with members of subgroups B and C. J. Virol. 64, 3661-3673.
5. DÖHRING, C., ANGMAN, L., SPAGNOLI, G., and LANZAVECCHIA, A. (1994). T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer 57, 754-759.
6. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.